NCT02059317

Brief Summary

The main objective of this study is to compare on day 0 the maximum Lyapunov exponent (lmax, an indicator of local dynamic stability) of chronic low back pain patients versus that of healthy volunteers matched for age (± 5 years), sex and body mass index (BMI ± 15% of low back pain patients).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 6, 2014

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 11, 2014

Completed
11 months until next milestone

Study Start

First participant enrolled

January 1, 2015

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 28, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 28, 2016

Completed
Last Updated

November 19, 2025

Status Verified

September 1, 2016

Enrollment Period

1.7 years

First QC Date

February 6, 2014

Last Update Submit

November 17, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • the Lyapunov exponent (lmax, an indicator of local dynamic stability)

    for flexion-extension movements The maximum Lyapunov exponent (lmax) is used to characterise local dynamic stability as in Rosenstein et al 1993 and Dingwell \& Kang 2007.

    Day 0 (baseline)

  • the Lyapunov exponent (lmax, an indicator of local dynamic stability)

    for rotational movements. The maximum Lyapunov exponent (lmax) is used to characterise local dynamic stability as in Rosenstein et al 1993 and Dingwell \& Kang 2007.

    Day 0 (baseline)

  • the Lyapunov exponent (lmax, an indicator of local dynamic stability)

    for complex movements. The maximum Lyapunov exponent (lmax) is used to characterise local dynamic stability as in Rosenstein et al 1993 and Dingwell \& Kang 2007.

    Day 0 (baseline)

Secondary Outcomes (6)

  • the Lyapunov exponent (lmax, an indicator of local dynamic stability)

    day 7

  • the Lyapunov exponent (lmax, an indicator of local dynamic stability)

    week 6

  • the Lyapunov exponent (lmax, an indicator of local dynamic stability)

    day 7

  • the Lyapunov exponent (lmax, an indicator of local dynamic stability)

    week 6

  • the Lyapunov exponent (lmax, an indicator of local dynamic stability)

    day 7

  • +1 more secondary outcomes

Other Outcomes (4)

  • Sex

    baseline (day 0)

  • Age

    baseline (day 0)

  • weight (kg)

    baseline (day 0)

  • +1 more other outcomes

Study Arms (6)

Group 1

Six groups are created in order to randomized the order of interventions. In group 1, the order of interventions is as follows: 1. Flexion-extension in the sagittal plane 2. Rotation in a transverse plane 3. Complex movement in three dimensions 2 minutes of rest and walking occurs between interventions. The above-mentioned exercises (1, 2 \& 3) are performed on day 0, day 7 and week 6 for patients, and only on day 0 for healthy volunteers.

Other: Flexion-extension in the sagittal planeOther: Rotation in a transverse planeOther: Complex movement in three dimensions

Group 2

Six groups are created in order to randomized the order of interventions. In group 2, the order of interventions is as follows: 1. Flexion-extension in the sagittal plane 2. Complex movement in three dimensions 3. Rotation in a transverse plane 2 minutes of rest and walking occurs between interventions. The above-mentioned exercises (1, 2 \& 3) are performed on day 0, day 7 and week 6 for patients, and only on day 0 for healthy volunteers.

Other: Flexion-extension in the sagittal planeOther: Rotation in a transverse planeOther: Complex movement in three dimensions

Group 3

Six groups are created in order to randomized the order of interventions. In group 3, the order of interventions is as follows: 1. Rotation in a transverse plane 2. Flexion-extension in the sagittal plane 3. Complex movement in three dimensions 2 minutes of rest and walking occurs between interventions. The above-mentioned exercises (1, 2 \& 3) are performed on day 0, day 7 and week 6 for patients, and only on day 0 for healthy volunteers.

Other: Flexion-extension in the sagittal planeOther: Rotation in a transverse planeOther: Complex movement in three dimensions

Group 4

Six groups are created in order to randomized the order of interventions. In group 4, the order of interventions is as follows: 1. Rotation in a transverse plane 2. Complex movement in three dimensions 3. Flexion-extension in the sagittal plane 2 minutes of rest and walking occurs between interventions. The above-mentioned exercises (1, 2 \& 3) are performed on day 0, day 7 and week 6 for patients, and only on day 0 for healthy volunteers.

Other: Flexion-extension in the sagittal planeOther: Rotation in a transverse planeOther: Complex movement in three dimensions

Group 5

Six groups are created in order to randomized the order of interventions. In group 5, the order of interventions is as follows: 1. Complex movement in three dimensions 2. Flexion-extension in the sagittal plane 3. Rotation in a transverse plane 2 minutes of rest and walking occurs between interventions. The above-mentioned exercises (1, 2 \& 3) are performed on day 0, day 7 and week 6 for patients, and only on day 0 for healthy volunteers.

Other: Flexion-extension in the sagittal planeOther: Rotation in a transverse planeOther: Complex movement in three dimensions

Group 6

Six groups are created in order to randomized the order of interventions. In group 6, the order of interventions is as follows: 1. Complex movement in three dimensions 2. Rotation in a transverse plane 3. Flexion-extension in the sagittal plane 2 minutes of rest and walking occurs between interventions. The above-mentioned exercises (1, 2 \& 3) are performed on day 0, day 7 and week 6 for patients, and only on day 0 for healthy volunteers.

Other: Flexion-extension in the sagittal planeOther: Rotation in a transverse planeOther: Complex movement in three dimensions

Interventions

The movement required is a flexion - extension where the subject touches a target (adapted to his/her morphology) with both index fingers: the target is positioned in front of the subject, inline with his/her outstretched arms and at knee height. This movement simulates a lifting task without weight. The movement is repeated 30 times with a return to the initial position at a frequency of 0.32Hz.

Group 1Group 2Group 3Group 4Group 5Group 6

The movement required of the subject is a rotational movement where the subject alternately touches with his/her left and right hands two targets. The latter are positioned horizontally on either side of the subject at shoulder height and at arm's length. The movement is repeated 30 times at a frequency of 0.28 Hz.

Group 1Group 2Group 3Group 4Group 5Group 6

The subject is required to successively touch 4 targets situated (i) at knee height to the left of the subject, (ii) at shoulder height to the right of the subject, (iii) at shoulder height to the left of the patient, and (iv) at knee height to the right of the patient. The movement is repeated 30 times at a frequency of 0.16 Hz.

Group 1Group 2Group 3Group 4Group 5Group 6

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients will be recruited during consultations in the department of Physical Medicine and Rehabilitation at the Nîmes University Hospital for lower back (lumbar) pain. The study population will include patients with chronic low back pain (lasting for more than 6 months and not postoperative). Healthy volunteers will be recruited at the Faculty of Medicine and the University Hospital of Nîmes.

You may qualify if:

  • The patient/subject must have given his/her informed and signed consent
  • The patient/subject must be insured or beneficiary of a health insurance plan
  • The patient has chronic low back pain lasting for more than 6 months and which is not postoperative in nature

You may not qualify if:

  • The patient/subject is participating in another study
  • The patient/subject is under judicial protection, under tutorship or curatorship
  • The patient/subject refuses to sign the consent
  • It is impossible to correctly inform the patient/subject
  • The patient/subject is pregnant, parturient, or breastfeeding
  • The patient has a history of spinal surgery
  • The patient has a history of preexisting postural disorder related to lumbalgia
  • The patient has undergone a localized infiltration treatment (e.g. cortisone shots) in the last month
  • The subject has a balance disorder, blindness, inability to carry out the experimental protocol
  • The subject has a history of acute low back pain \> 15 days or which has resulted in a work stoppage of more than 7 days in the 5 years preceding the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHRU de Nîmes - Hôpital Universitaire Carémeau

Nîmes, 30029, France

Location

Related Publications (1)

  • Graham RB, Dupeyron A, van Dieen JH. Between-day reliability of IMU-derived spine control metrics in patients with low back pain. J Biomech. 2020 Dec 2;113:110080. doi: 10.1016/j.jbiomech.2020.110080. Epub 2020 Oct 23.

MeSH Terms

Conditions

Low Back Pain

Interventions

Rotation

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

MotionPhysical Phenomena

Study Officials

  • Arnaud Dupeyron, MD, PhD

    Centre Hospitalier Universitaire de Nîmes

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 6, 2014

First Posted

February 11, 2014

Study Start

January 1, 2015

Primary Completion

September 28, 2016

Study Completion

September 28, 2016

Last Updated

November 19, 2025

Record last verified: 2016-09

Locations